{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:19:29Z","timestamp":1791299969105,"version":"4.1.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073923"],"award-info":[{"award-number":["82073923"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003849"],"award-info":[{"award-number":["82003849"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.dmd.2025.100172","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:37:14Z","timestamp":1758760634000},"page":"100172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Activation of pregnane X receptor-organic anion transporting polypeptide 1a\/b \/P-glycoprotein\/multidrug resistance protein 2 axis mediates the accelerated blood and liver clearance of PEGylated liposomes"],"prefix":"10.1016","volume":"53","author":[{"given":"Jianquan","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiya","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunna","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7787-2638","authenticated-orcid":false,"given":"Weidong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Pt A","key":"10.1016\/j.dmd.2025.100172_bib1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"10.1016\/j.dmd.2025.100172_bib2","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/s41467-017-00600-w","article-title":"Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics","volume":"8","author":"Bertrand","year":"2017","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.dmd.2025.100172_bib3","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0022-3565(24)35391-1","article-title":"Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes","volume":"292","author":"Dams","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"issue":"28","key":"10.1016\/j.dmd.2025.100172_bib4","doi-asserted-by":"crossref","first-page":"17955","DOI":"10.1021\/acsami.6b05840","article-title":"Accelerated blood clearance phenomenon reduces the passive targeting of PEGylated nanoparticles in peripheral arterial disease","volume":"8","author":"Im","year":"2016","journal-title":"ACS Appl Mater Interfaces"},{"issue":"4","key":"10.1016\/j.dmd.2025.100172_bib5","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1021\/acs.molpharmaceut.9b00770","article-title":"Accelerated blood clearance of nanoemulsions modified with PEG-cholesterol and PEG-phospholipid derivatives in rats: the effect of PEG-lipid linkages and PEG molecular weights","volume":"17","author":"Liu","year":"2020","journal-title":"Mol Pharm"},{"issue":"1","key":"10.1016\/j.dmd.2025.100172_bib6","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12951-025-03209-0","article-title":"Emerging strategies against accelerated blood clearance phenomenon of nanocarrier drug delivery systems","volume":"23","author":"Pan","year":"2025","journal-title":"J Nanobiotechnol"},{"issue":"8","key":"10.1016\/j.dmd.2025.100172_bib7","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1124\/dmd.119.086769","article-title":"Activation of pregnane X receptor-cytochrome P450s axis: a possible reason for the enhanced accelerated blood clearance phenomenon of PEGylated liposomes in vivo","volume":"47","author":"Wang","year":"2019","journal-title":"Drug Metab Dispos"},{"issue":"12","key":"10.1016\/j.dmd.2025.100172_bib8","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1124\/dmd.123.001496","article-title":"Activation of CYP3A by accelerated blood clearance phenomenon potentiates the hepatocellular carcinoma-targeting therapeutic effects of PEGylated anticancer prodrug liposomes","volume":"51","author":"Zhang","year":"2023","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"10.1016\/j.dmd.2025.100172_bib9","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1124\/dmd.118.085340","article-title":"Induction of cytochrome P450 involved in the accelerated blood clearance phenomenon induced by PEGylated liposomes in vivo","volume":"47","author":"Wang","year":"2019","journal-title":"Drug Metab Dispos"},{"issue":"18","key":"10.1016\/j.dmd.2025.100172_bib10","doi-asserted-by":"crossref","first-page":"14581","DOI":"10.1074\/jbc.M010173200","article-title":"Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin","volume":"276","author":"Geick","year":"2001","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.dmd.2025.100172_bib11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1124\/jpet.300.1.97","article-title":"Organ distribution of multidrug resistance proteins 1, 2, and 3 (Mrp1, 2, and 3) mRNA and hepatic induction of Mrp3 by constitutive androstane receptor activators in rats","volume":"300","author":"Cherrington","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"10.1016\/j.dmd.2025.100172_bib12","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00424-003-1168-y","article-title":"Organic anion transporting polypeptides of the OATP\/ SLC21 family: phylogenetic classification as OATP\/ SLCO superfamily, new nomenclature and molecular\/functional properties","volume":"447","author":"Hagenbuch","year":"2004","journal-title":"Pflugers Arch"},{"issue":"8","key":"10.1016\/j.dmd.2025.100172_bib13","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.bbadis.2011.01.014","article-title":"Nuclear receptor PXR, transcriptional circuits and metabolic relevance","volume":"1812","author":"Ihunnah","year":"2011","journal-title":"Bochim Biophys Acta"},{"issue":"5","key":"10.1016\/j.dmd.2025.100172_bib14","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.apsb.2019.11.007","article-title":"Characterization of organic anion transporting polypeptide 1b2 knockout rats generated by CRISPR\/Cas9: a novel model for drug transport and hyperbilirubinemia disease","volume":"10","author":"Ma","year":"2020","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"10.1016\/j.dmd.2025.100172_bib15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0022-3565(24)39041-X","article-title":"Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier","volume":"294","author":"Gao","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"issue":"10","key":"10.1016\/j.dmd.2025.100172_bib16","doi-asserted-by":"crossref","first-page":"9610","DOI":"10.1074\/jbc.M411092200","article-title":"Polymorphisms in human organic anion-transporting polypeptide 1A2 (OATP1A2): implications for altered drug disposition and central nervous system drug entry","volume":"280","author":"Lee","year":"2005","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.dmd.2025.100172_bib17","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/sj.clpt.6100056","article-title":"Intestinal drug transporter expression and the impact of grapefruit juice in humans","volume":"81","author":"Glaeser","year":"2007","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.dmd.2025.100172_bib18","doi-asserted-by":"crossref","first-page":"G156","DOI":"10.1152\/ajpgi.2000.278.1.G156","article-title":"A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane","volume":"278","author":"K\u00f6nig","year":"2000","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"10.1016\/j.dmd.2025.100172_bib19","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1006\/bbrc.2000.2922","article-title":"Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family","volume":"273","author":"Tamai","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"10.1016\/j.dmd.2025.100172_bib20","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1053\/gast.2001.24804","article-title":"LST-2, A human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers","volume":"120","author":"Abe","year":"2001","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.dmd.2025.100172_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.109.002014","article-title":"Xenobiotic, bile acid, and cholesterol transporters: function and regulation","volume":"62","author":"Klaassen","year":"2010","journal-title":"Pharmacol Rev"},{"issue":"2","key":"10.1016\/j.dmd.2025.100172_bib22","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pharep.2017.10.005","article-title":"P-gp is involved in the intestinal absorption and biliary excretion of afatinib in vitro and in rats","volume":"70","author":"Zhang","year":"2018","journal-title":"Pharmacol Rep"},{"issue":"10","key":"10.1016\/j.dmd.2025.100172_bib23","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.3390\/pharmaceutics13101544","article-title":"Inflammation induces changes in the functional expression of P-gp, BCRP, and MRP2: an overview of different models and consequences for drug disposition","volume":"13","author":"Saib","year":"2021","journal-title":"Pharmaceutics"},{"issue":"43","key":"10.1016\/j.dmd.2025.100172_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201901782","article-title":"Phospholipid-free small unilamellar vesicles for drug targeting to cells in the liver","volume":"15","author":"Zhang","year":"2019","journal-title":"Small"},{"issue":"3","key":"10.1016\/j.dmd.2025.100172_bib25","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0090-9556(24)15360-3","article-title":"The role of mdr1a P-glycoprotein in the biliary and intestinal secretion of doxorubicin and vinblastine in mice","volume":"28","author":"van Asperen","year":"2000","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1016\/j.dmd.2025.100172_bib26","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1124\/jpet.106.101774","article-title":"Carcinogen and anticancer drug transport by Mrp2 in vivo: studies using Mrp2 (Abcc2) knockout mice","volume":"318","author":"Vlaming","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"issue":"7","key":"10.1016\/j.dmd.2025.100172_bib27","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1002\/ijc.28797","article-title":"In vivodisposition of doxorubicin is affected by mouse Oatp1a\/1b and human OATP1A\/1B transporters","volume":"135","author":"Durmus","year":"2014","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.dmd.2025.100172_bib28","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1124\/mol.116.105544","article-title":"Contribution of organic anion-transporting polypeptides 1A\/1B to doxorubicin uptake and clearance","volume":"91","author":"Lee","year":"2017","journal-title":"Mol Pharmacol"},{"issue":"2","key":"10.1016\/j.dmd.2025.100172_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2020.100086","article-title":"Protocol for primary mouse hepatocyte isolation","volume":"1","author":"Charni-Natan","year":"2020","journal-title":"STAR Protoc"},{"issue":"45","key":"10.1016\/j.dmd.2025.100172_bib30","doi-asserted-by":"crossref","first-page":"28574","DOI":"10.1074\/jbc.272.45.28574","article-title":"Cytokeratin 18 is expressed on the hepatocyte plasma membrane surface and interacts with thrombin-antithrombin complexes","volume":"272","author":"Wells","year":"1997","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.dmd.2025.100172_bib31","doi-asserted-by":"crossref","first-page":"5186","DOI":"10.4238\/2013.October.30.3","article-title":"Isolation and identification of bovine primary hepatocytes","volume":"12","author":"Jiang","year":"2013","journal-title":"Genet Mol Res"},{"issue":"6","key":"10.1016\/j.dmd.2025.100172_bib32","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0090-9556(24)15299-3","article-title":"Correlation of biliary excretion in sandwich-cultured rat hepatocytes and in vivo in rats","volume":"27","author":"Liu","year":"1999","journal-title":"Drug Metab Dispos"},{"issue":"8","key":"10.1016\/j.dmd.2025.100172_bib33","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.bcp.2010.06.043","article-title":"Dexamethasone transcriptionally increases the expression of the pregnane X receptor and synergistically enhances pyrethroid esfenvalerate in the induction of cytochrome P450 3A23","volume":"80","author":"Shi","year":"2010","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.dmd.2025.100172_bib34","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jphs.2019.04.007","article-title":"Dexamethasone changes the pharmacokinetics of amitriptyline and reduces its accumulation in rat brain: the roles of P-gp and cyp3a2","volume":"140","author":"Wen","year":"2019","journal-title":"J Pharmacol Sci"},{"issue":"9","key":"10.1016\/j.dmd.2025.100172_bib35","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1124\/dmd.120.000061","article-title":"Dexamethasone-induced liver enlargement is related to PXR\/YAP activation and lipid accumulation but not hepatocyte proliferation","volume":"48","author":"Jiao","year":"2020","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"10.1016\/j.dmd.2025.100172_bib36","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/08982104.2016.1191021","article-title":"PEGylated niosomes-mediated drug delivery systems for Paeonol: preparation, pharmacokinetics studies and synergistic anti-tumor effects with 5-FU","volume":"27","author":"He","year":"2017","journal-title":"J Liposome Res"},{"issue":"6","key":"10.1016\/j.dmd.2025.100172_bib37","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1124\/dmd.108.025544","article-title":"Long-lasting inhibition of the transporter-mediated hepatic uptake of sulfobromophthalein by cyclosporin A in rats","volume":"37","author":"Shitara","year":"2009","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1016\/j.dmd.2025.100172_bib38","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s40262-013-0097-y","article-title":"A mechanistic framework for in vitro\u2013in vivo extrapolation of liver membrane transporters: prediction of drug\u2013drug interaction between rosuvastatin and cyclosporine","volume":"53","author":"Jamei","year":"2014","journal-title":"Clin Pharmacokinet"},{"issue":"48","key":"10.1016\/j.dmd.2025.100172_bib39","doi-asserted-by":"crossref","first-page":"30038","DOI":"10.1039\/C7RA03537C","article-title":"Liver uptake of cefditoren is mediated by OATP1B1 and OATP2B1 in humans and Oatp1a1, Oatp1a4, and Oatp1b2 in rats","volume":"7","author":"Wang","year":"2017","journal-title":"RSC Adv"},{"issue":"4","key":"10.1016\/j.dmd.2025.100172_bib40","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.dmpk.2020.03.005","article-title":"Increased plasma concentrations of an antidyslipidemic drug pemafibrate co-administered with rifampicin or cyclosporine A in cynomolgus monkeys genotyped for the organic anion transporting polypeptide 1B1","volume":"35","author":"Ogawa","year":"2020","journal-title":"Drug Metab Pharmacokinet"},{"issue":"10","key":"10.1016\/j.dmd.2025.100172_bib41","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1002\/jps.10199","article-title":"Effect of interferons on P-glycoprotein-mediated rhodamine-123 efflux in cultured rat hepatocytes","volume":"91","author":"Akazawa","year":"2002","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.dmd.2025.100172_bib42","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1124\/jpet.102.044107","article-title":"Pharmacokinetics of 5 (and 6)-carboxy-2\u2032,7\u2032-dichlorofluorescein and its diacetate promoiety in the liver","volume":"304","author":"Zamek-Gliszczynski","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"10.1016\/j.dmd.2025.100172_bib43","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/j.xphs.2016.01.020","article-title":"Effects of polyoxyethylene alkyl ethers on the intestinal transport and absorption of Rhodamine 123: a P-glycoprotein substrate by in vitro and in vivo studies","volume":"105","author":"Zhao","year":"2016","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.dmd.2025.100172_bib44","article-title":"Overexpression of ABCC1 confers drug resistance to betulin","volume":"11","author":"Chen","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.dmd.2025.100172_bib45","doi-asserted-by":"crossref","first-page":"103207","DOI":"10.1016\/j.redox.2024.103207","article-title":"Redistribution of defective mitochondria-mediated dihydroorotate dehydrogenase imparts 5-fluorouracil resistance in colorectal cancer","volume":"73","author":"Dong","year":"2024","journal-title":"Redox Biol"},{"issue":"7","key":"10.1016\/j.dmd.2025.100172_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202350825","article-title":"The immunosuppressive drug cyclosporin A has an immunostimulatory function in CD8+ T cells","volume":"54","author":"Wi\u00dffeld","year":"2024","journal-title":"Eur J Immunol"},{"issue":"1","key":"10.1016\/j.dmd.2025.100172_bib47","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1080\/13880209.2021.1871634","article-title":"Influence of verapamil on the pharmacokinetics of rotundic acid in rats and its potential mechanism","volume":"59","author":"Shang","year":"2021","journal-title":"Pharm Biol"},{"issue":"7","key":"10.1016\/j.dmd.2025.100172_bib48","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1172\/JCI45023","article-title":"Inhibition of MRP4 prevents and reverses pulmonary hypertension in mice","volume":"121","author":"Hara","year":"2011","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.dmd.2025.100172_bib49","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41401-019-0283-z","article-title":"Leflunomide increased the renal exposure of acyclovir by inhibiting OAT1\/3 and MRP2","volume":"41","author":"Liao","year":"2020","journal-title":"Acta Pharmacol Sin"},{"issue":"1-2","key":"10.1016\/j.dmd.2025.100172_bib50","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ijpharm.2013.01.012","article-title":"Prolongation of time interval between doses could eliminate accelerated blood clearance phenomenon induced by pegylated liposomal topotecan","volume":"443","author":"Li","year":"2013","journal-title":"Int J Pharm"},{"issue":"4","key":"10.1016\/j.dmd.2025.100172_bib51","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s11095-012-0934-y","article-title":"Accelerated blood clearance of PEGylated PLGA nanoparticles following repeated injections: effects of polymer dose, PEG coating, and encapsulated anticancer drug","volume":"30","author":"Saadati","year":"2013","journal-title":"Pharm Res"},{"issue":"1","key":"10.1016\/j.dmd.2025.100172_bib52","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.xphs.2018.10.027","article-title":"Time interval of two injections and first-dose dependent of accelerated blood clearance phenomenon induced by PEGylated liposomal gambogenic acid: the contribution of PEG-specific IgM","volume":"108","author":"Wang","year":"2019","journal-title":"J Pharm Sci"},{"issue":"5","key":"10.1016\/j.dmd.2025.100172_bib53","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3109\/10717544.2014.885998","article-title":"Influence of phospholipid types and animal models on the accelerated blood clearance phenomenon of PEGylated liposomes upon repeated injection","volume":"22","author":"Xu","year":"2015","journal-title":"Drug Deliv"},{"issue":"1","key":"10.1016\/j.dmd.2025.100172_bib54","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1038\/s41467-024-48838-5","article-title":"Rediscovery of mononuclear phagocyte system blockade for nanoparticle drug delivery","volume":"15","author":"Zelepukin","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.dmd.2025.100172_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119839","article-title":"Experimental respiratory exposure to putative Gulf War toxins promotes persistent alveolar macrophage recruitment and pulmonary inflammation","volume":"282","author":"Powers","year":"2021","journal-title":"Life Sci"},{"issue":"2","key":"10.1016\/j.dmd.2025.100172_bib56","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jconrel.2007.02.010","article-title":"Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes","volume":"119","author":"Wang","year":"2007","journal-title":"J Control Release"},{"issue":"7","key":"10.1016\/j.dmd.2025.100172_bib57","doi-asserted-by":"crossref","first-page":"7682","DOI":"10.1021\/acsnano.0c03648","article-title":"Complement activation: a potential threat on the safety of poly(ethylene glycol)-coated nanomedicines","volume":"14","author":"Gabizon","year":"2020","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.dmd.2025.100172_bib58","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3390\/molecules24040707","article-title":"Newly synthesized oxygenated xanthones as potential P-glycoprotein activators: in vitro, ex vivo, and in silico studies","volume":"24","author":"Martins","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.dmd.2025.100172_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2019.114832","article-title":"P-glycoprotein activation by 1-(propan-2-ylamino)-4-propoxy-9H-thioxanthen-9-one (TX5) in rat distal ileum: ex vivo and in vivo studies","volume":"386","author":"Rocha-Pereira","year":"2020","journal-title":"Toxicol Appl Pharmacol"},{"issue":"3","key":"10.1016\/j.dmd.2025.100172_bib60","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3109\/03602530903491881","article-title":"Sandwich-cultured hepatocytes: anin vitromodel to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity","volume":"42","author":"Swift","year":"2010","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.dmd.2025.100172_bib61","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jconrel.2023.03.017","article-title":"cRGD-targeted heparin nanoparticles for effective dual drug treatment of cisplatin-resistant ovarian cancer","volume":"356","author":"Liang","year":"2023","journal-title":"J Control Release"},{"issue":"2","key":"10.1016\/j.dmd.2025.100172_bib62","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ejpb.2008.08.010","article-title":"A Caco-2 cell based screening method for compounds interacting with MRP2 efflux protein","volume":"71","author":"Siissalo","year":"2009","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"10.1016\/j.dmd.2025.100172_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119502","article-title":"Regulation of multidrug resistance proteins by genistein in a hepatocarcinoma cell line: impact on sorafenib cytotoxicity","volume":"10","author":"Rigalli","year":"2015","journal-title":"Plos One"},{"issue":"1","key":"10.1016\/j.dmd.2025.100172_bib64","doi-asserted-by":"crossref","first-page":"6136","DOI":"10.1038\/s41467-024-50568-7","article-title":"Kupffer cells determine intrahepatic traffic of PEGylated liposomal doxorubicin","volume":"15","author":"Jiang","year":"2024","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.dmd.2025.100172_bib65","doi-asserted-by":"crossref","first-page":"124","DOI":"10.2174\/1389200219666181003142036","article-title":"Drug-drug interactions of P-gp substrates unrelated to CYP metabolism","volume":"20","author":"Akamine","year":"2019","journal-title":"Curr Drug Metab"},{"issue":"6","key":"10.1016\/j.dmd.2025.100172_bib66","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s40262-020-00867-1","article-title":"Effect of P-glycoprotein (P-gp) inducers on exposure of P-gp substrates: review of clinical drug\u2013drug interaction studies","volume":"59","author":"Elmeliegy","year":"2020","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"10.1016\/j.dmd.2025.100172_bib67","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0022-3565(24)29419-2","article-title":"Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection","volume":"298","author":"Laverman","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"issue":"8","key":"10.1016\/j.dmd.2025.100172_bib68","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1208\/s12249-020-01838-2","article-title":"The contribution of PEG molecular weights in PEGylated emulsions to the various phases in the accelerated blood clearance (ABC) phenomenon in rats","volume":"21","author":"Jiao","year":"2020","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"10.1016\/j.dmd.2025.100172_bib69","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1080\/14686996.2019.1627174","article-title":"PEGylated liposomes: immunological responses","volume":"20","author":"Mohamed","year":"2019","journal-title":"Sci Technol Adv Mater"},{"key":"10.1016\/j.dmd.2025.100172_bib70","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jconrel.2023.10.023","article-title":"Ginsenoside Rg3 endows liposomes with prolonged blood circulation and reduced accelerated blood clearance","volume":"364","author":"Xia","year":"2023","journal-title":"J Control Release"},{"key":"10.1016\/j.dmd.2025.100172_bib71","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jconrel.2020.04.011","article-title":"Hepatosplenic phagocytic cells indirectly contribute to anti-PEG IgM production in the accelerated blood clearance (ABC) phenomenon against PEGylated liposomes: appearance of an unexplained mechanism in the ABC phenomenon","volume":"323","author":"El Sayed","year":"2020","journal-title":"J Control Release"},{"issue":"7","key":"10.1016\/j.dmd.2025.100172_bib72","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1021\/acs.molpharmaceut.8b00042","article-title":"Use of dual-ligand modification in Kupffer cell-targeted liposomes to examine the contribution of Kupffer cells to accelerated blood clearance phenomenon","volume":"15","author":"Lai","year":"2018","journal-title":"Mol Pharm"},{"issue":"4","key":"10.1016\/j.dmd.2025.100172_bib73","first-page":"455","article-title":"Effect of Kupffer cells depletion on ABC phenomenon induced by Kupffer cells-targeted liposomes","volume":"14","author":"Lai","year":"2019","journal-title":"Asian J Pharm Sci"},{"issue":"11","key":"10.1016\/j.dmd.2025.100172_bib74","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1124\/dmd.106.010520","article-title":"Regulation of mRNA expression of xenobiotic transporters by the pregnane X receptor in mouse liver, kidney, and intestine","volume":"34","author":"Cheng","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2025.100172_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110133","article-title":"Pregnane X receptor promotes liver enlargement in mice through the spatial induction of hepatocyte hypertrophy and proliferation","volume":"367","author":"Tian","year":"2022","journal-title":"Chem Biol Interact"},{"issue":"2","key":"10.1016\/j.dmd.2025.100172_bib76","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/hep.20784","article-title":"CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice","volume":"42","author":"Wagner","year":"2005","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.dmd.2025.100172_bib77","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/cpt.1072","article-title":"Cytochrome P450 3A induction predicts P-glycoprotein induction; part 2: prediction of decreased substrate exposure after rifabutin or carbamazepine","volume":"104","author":"Lutz","year":"2018","journal-title":"Clin Pharmacol Ther"},{"issue":"20","key":"10.1016\/j.dmd.2025.100172_bib78","doi-asserted-by":"crossref","first-page":"15122","DOI":"10.1074\/jbc.M001215200","article-title":"Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands","volume":"275","author":"Moore","year":"2000","journal-title":"J Biol Chem"},{"issue":"1-2","key":"10.1016\/j.dmd.2025.100172_bib79","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejps.2008.06.008","article-title":"Identification of interspecies difference in efflux transporters of hepatocytes from dog, rat, monkey and human","volume":"35","author":"Li","year":"2008","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10.1016\/j.dmd.2025.100172_bib80","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/hep.30131","article-title":"Pregnane X receptor regulates liver size and liver cell fate by Yes-associated protein activation in mice","volume":"69","author":"Jiang","year":"2019","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.dmd.2025.100172_bib81","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.ajpath.2014.01.025","article-title":"Transgenic expression of the human MRP2 transporter reduces cisplatin accumulation and nephrotoxicity in Mrp2-null mice","volume":"184","author":"Wen","year":"2014","journal-title":"Am J Pathol"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955625094814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955625094814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:55:57Z","timestamp":1763754957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955625094814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":81,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0090955625094814"],"URL":"https:\/\/doi.org\/10.1016\/j.dmd.2025.100172","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activation of pregnane X receptor-organic anion transporting polypeptide 1a\/b \/P-glycoprotein\/multidrug resistance protein 2 axis mediates the accelerated blood and liver clearance of PEGylated liposomes","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmd.2025.100172","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100172"}}